Loading
Life sciences · Review
Journal of Alzheimer S Disease · October 24, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Review.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Dementia is a progressive neurodegenerative disorder characterized by cognitive decline that compromises daily functioning, with Alzheimer's disease (AD) representing its most prevalent form. Mild cognitive impairment (MCI) represents a prodromal stage of AD and provides an important window for early intervention. Woohwangchungsimwon (WCW) is a multicomponent natural medicinal formulation historically used to promote cardiovascular and neurological stability and to alleviate excessive heat and phlegm. This review evaluated the potential of WCW to ameliorate symptoms associated with dementia and MCI. A narrative review of experimental and pharmacological studies was conducted to examine the bioactive compounds, bioactivities, mechanisms, and reported outcomes of eight key natural medicinal components of WCW: Angelicae Gigantis Radix, Calculus Bovis, Cinnamomi Cortex, Dioscoreae Rhizoma, Ginseng Radix, Glycyrrhizae Radix, Hoelen and Zingiberis Rhizoma, which possess neuroprotective, anti-inflammatory and antioxidant activities. Although current evidence regarding WCW and its active components is derived predominantly from preclinical models and studies conducted within broader neurological contexts, its multicomponent nature suggests significant potential for targeting multiple pathological processes relevant to dementia and MCI. Well-designed clinical trials are now needed to clarify the therapeutic efficacy and safety of WCW in patients with cognitive impairment.